Maternal Sterility Construct for Fish Population Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for sterilizing fish and other aquatic species are labor-intensive, species-dependent, and often incomplete, with challenges in ensuring 100% sterility and reversibility, particularly when using hormone-based approaches or bacterial repression systems, which can be costly and environmentally hazardous.
Innovation Solution
A transgenic technology platform using a Maternal Sterility Construct (MSC) that includes a promoter, a polynucleotide sequence capable of ablating Primordial Germ Cells (PGCs), and germ cell-specific cis-acting elements, allowing for efficient sterilization of vertebrate and invertebrate animals without harmful agents, enabling 100% effective sterilization and easy propagation of transgenic lines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hormone-based approaches or bacterial repression systems are used to achieve sterility, then sterility can be induced, but production costs increase and environmental hazards are created
Solution Approach 1:
The patent extracts and eliminates the need for harmful external agents (hormones, antibiotics, bacterial repression systems) by implementing an endogenous self-regulating mechanism. The transgenic system uses a promoter that is naturally activated by the absence of germ cells to drive expression of a sterility-inducing gene, thereby achieving sterility through the organism's own biological machinery rather than external chemical or biological agents.
Solution Approach 2:
The sterility mechanism is designed to be self-regulating and self-sustaining. The promoter's activity is automatically triggered when germ cells are absent or reduced, creating a feedback loop that maintains sterility without requiring external intervention. This self-service mechanism eliminates the need for continuous administration of hormones or antibiotics, thereby reducing environmental hazards and production costs.
2Reliability
If traditional triploid induction or hormone silencing methods are used, then sterility can be achieved, but labor intensity increases and sterility completeness cannot be guaranteed at 100%
Solution Approach 1:
The sterility mechanism is established at the genetic level during transgenic integration, before the organism reaches maturity. The transgene is incorporated into the genome in such a way that it is poised to activate automatically under specific conditions (absence of germ cells), thereby pre-programming sterility rather than requiring labor-intensive interventions during later stages.
Solution Approach 2:
The system incorporates a feedback mechanism where the promoter's activity is directly responsive to the presence or absence of germ cells. When germ cells are absent, the promoter activates to drive expression of the sterility-inducing gene, which in turn maintains the absence of germ cells. This self-reinforcing feedback loop ensures 100% sterility completeness without requiring manual verification or adjustment.
3Productivity
If transgenic lines are propagated using existing methods, then propagation can occur, but repeated treatment with harmful agents is required at each generation
Solution Approach 1:
The patent applies sterility induction selectively and partially - only in the specific context where the promoter is activated (when germ cells are absent). This partial action approach allows the transgenic line to be propagated efficiently without requiring excessive or repeated treatment at each generation, as the mechanism is built into the genetic architecture rather than requiring external application.
Solution Approach 2:
The system changes the fundamental parameter of sterility induction from external chemical/biological treatment to endogenous genetic regulation. By altering the mode of action from exogenous to endogenous, the need for repeated treatments is eliminated, as the sterility mechanism is automatically maintained through the organism's own genetic programming across generations.
Data Source
AI summary
The present invention provides Maternal Sterility Constructs (MSC) and methods of producing sterile progeny lacking germ cells. Female fish carrying the MSC transgene will give rise to a sterile generation, as the MSC specifically eliminates Progenitor Germ Cells (PGCs) of her progeny. These females are called lineage ending females. Male fish carrying the MSC transgene, however, give rise to fertile progeny (assuming the male is not derived from an MSC-transgenic female). Thus, MSC transgenic males can be used to propagate the transgenic line. The invention can be advantageously applied to provide effective population control and improve culture performance of farmed species, such as fish.